NEONATAL AND INFANT PROBLEMS OF LOW BIRTH WEIGHT
NEONATAL AND INFANT PROBLEMS OF LOW BIRTH WEIGHT
复制标题
低出生体重的新生儿和婴儿问题
DOI：
10.1097/00001703-199102000-00003
复制
发表时间：
1991
影响因子：
2.1
通讯作者：
A. Rosenberg
中科院分区：
文献类型：
--
作者：
A. Rosenberg
正在开发新的治疗方法，以提高低出生体重婴儿的存活率，特别是体重低于1000 g的婴儿。最令人兴奋的新进展是使用表面活性物质替代疗法治疗呼吸窘迫综合征。这种疗法导致不太严重的急性肺部疾病，并降低了呼吸窘迫综合征的死亡率。随着越来越多的婴儿存活，考虑长期后遗症，包括慢性肺部疾病和神经系统的结果是至关重要的。本文综述了呼吸窘迫综合征的预防和治疗策略（包括表面活性物质替代）。新的和不断发展的治疗方法，以改善慢性肺部疾病和问题，在神经系统的结果，为低出生体重婴儿（包括预防脑室内出血）。
New therapies are being developed to improve survival of low-birth-weight infants, especially those weighing less than 1000 g. The most exciting new development is the use of surfactant replacement therapy for treatment of respiratory distress syndrome. This therapy results in less severe acute lung disease and has decreased mortality from respiratory distress syndrome. As more infants survive, consideration of long-term sequelae including chronic lung disease and neurologic outcome are of paramount importance. This review covers strategies for prevention and treatment of respiratory distress syndrome (including surfactant replacement). New and evolving treatments for amelioration of chronic lung disease and issues in neurologic outcome for the low-birth-weight infant (including prevention of intraventricular hemorrhage) are addressed.